- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleocapsid as a next-generation COVID-19 vaccine candidate
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 122, Issue -, Pages 529-530
Publisher
Elsevier BV
Online
2022-07-04
DOI
10.1016/j.ijid.2022.06.046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- Effectiveness of COVID-19 booster vaccines against covid-19 related symptoms, hospitalisation and death in England
- (2022) Nick Andrews et al. NATURE MEDICINE
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Jill M. Ferdinands et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
- (2022) Timothy A. Bates et al. Science Immunology
- Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
- (2022) Jin Young Ahn et al. Lancet Microbe
- Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats
- (2022) Everidiene K. V. B. Silva et al. PLoS One
- Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
- (2022) Haoyue Cheng et al. Vaccines
- Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
- (2021) Matthew K Hensley et al. CLINICAL INFECTIOUS DISEASES
- CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
- (2021) Thi H.O. Nguyen et al. IMMUNITY
- Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
- (2021) Thao T. Truong et al. EBioMedicine
- Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs
- (2021) Min Thura et al. BIOSCIENCE REPORTS
- Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion
- (2021) Veronique Nussenblatt et al. JOURNAL OF INFECTIOUS DISEASES
- Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection
- (2021) Harika Oyku Dinc et al. VACCINE
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- (2020) Noton K. Dutta et al. JOURNAL OF VIROLOGY
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
- (2020) Omna Sharma et al. Frontiers in Immunology
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- (2020) Victoria A. Avanzato et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started